Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lamin tail domain-containing protein 1 (LMNTD1) is a human protein of 165 amino acids, encoded by the gene LMNTD1[2][8]. It contains a tail domain homologous to those found in intermediate filament and nuclear lamina proteins, but its specific function remains unclear[1]. It is predicted to localize to the cytoplasm and the nuclear envelope and may participate in cell population proliferation, likely functioning in cellular structure or organization rather than in signaling or direct enzymatic activity[4][7]. No established role as a receptor, transporter, or traditional therapeutic target is described, and there are no clinically relevant drugs, biomarkers, or disease associations definitively connected to LMNTD1. Protein-protein interaction data suggest in vitro association with amyloid precursor protein (APP), but this does not establish a therapeutic or diagnostic application[5]. Its biological functions and pathological relevance remain largely uncharacterized[1][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lamin tail domain-containing protein 1 (LMNTD1).